VAIA, PAOLO
 Distribuzione geografica
Continente #
EU - Europa 1.148
NA - Nord America 488
AS - Asia 446
SA - Sud America 68
Continente sconosciuto - Info sul continente non disponibili 26
AF - Africa 12
Totale 2.188
Nazione #
RU - Federazione Russa 920
US - Stati Uniti d'America 459
IT - Italia 167
SG - Singapore 155
CN - Cina 112
VN - Vietnam 67
BR - Brasile 52
HK - Hong Kong 31
IN - India 16
KR - Corea 16
DE - Germania 14
JP - Giappone 14
CA - Canada 11
MX - Messico 10
FR - Francia 9
GB - Regno Unito 9
NL - Olanda 8
AT - Austria 7
ID - Indonesia 7
AR - Argentina 6
BD - Bangladesh 5
EC - Ecuador 5
ZA - Sudafrica 5
CO - Colombia 4
ES - Italia 4
PK - Pakistan 4
EG - Egitto 3
FI - Finlandia 3
IQ - Iraq 3
MY - Malesia 3
PL - Polonia 3
TR - Turchia 3
UZ - Uzbekistan 3
TT - Trinidad e Tobago 2
UA - Ucraina 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BB - Barbados 1
BS - Bahamas 1
CH - Svizzera 1
CR - Costa Rica 1
DZ - Algeria 1
ET - Etiopia 1
HN - Honduras 1
IE - Irlanda 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
NI - Nicaragua 1
PH - Filippine 1
PR - Porto Rico 1
SC - Seychelles 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
VE - Venezuela 1
Totale 2.162
Città #
Moscow 316
San Jose 94
Singapore 84
Ashburn 75
Council Bluffs 48
Naples 33
Ho Chi Minh City 32
Hong Kong 31
Hefei 25
Dallas 20
Milan 20
Beijing 19
Seoul 16
Santa Clara 15
Hanoi 12
Los Angeles 10
Rome 10
Bengaluru 7
Chicago 7
Mexico City 7
São Paulo 7
Da Nang 6
Denver 6
Frankfurt am Main 6
Montreal 6
North Bergen 6
Fondi 5
New York 5
Orem 5
San Francisco 5
Bari 4
Casoria 4
Memphis 4
Miano 4
Newark 4
Sialkot 4
Viterbo 4
Amsterdam 3
Atlanta 3
Chennai 3
Kochi 3
Pavia 3
Phoenix 3
Tashkent 3
Tokyo 3
Vienna 3
Baghdad 2
Boardman 2
Brasília 2
Cairo 2
Cape Town 2
Chaguanas 2
City of London 2
Detroit 2
Florence 2
Genoa 2
Guayaquil 2
Hangzhou 2
Helsinki 2
Hillsboro 2
Limburg an der Lahn 2
Lübeck 2
Manchester 2
Mogi das Cruzes 2
Ninh Bình 2
Nuremberg 2
Porto Alegre 2
Rio Paranaíba 2
San Cesareo 2
San Luis 2
Sant'Antonio Abate 2
Shanghai 2
The Bronx 2
Toronto 2
Ubatuba 2
Verona 2
Vũng Tàu 2
Warsaw 2
Washington 2
Abano Terme 1
Addis Ababa 1
Al Ain City 1
Alexandria 1
Almaty 1
An Giang Province 1
Anagé 1
Ankara 1
Anápolis 1
Aversa 1
Barcelona 1
Baton Rouge 1
Belo Horizonte 1
Bertioga 1
Bethlehem 1
Bishkek 1
Biên Hòa 1
Bogotá 1
Bologna 1
Bom Retiro do Sul 1
Boston 1
Totale 1.080
Nome #
Dysgeusia in MASLD-related advanced chronic liver disease (ACLD): a silent driver towards the "Bermuda" triangle of malnutrition-sarcopenia-frailty severely affecting prognosis 165
FLAME: Training and Validating a Newly Conceived Model Incorporating Alpha-Glutathione-S-Transferase Serum Levels for Predicting Advanced Hepatic Fibrosis and Acute Cardiovascular Events in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) 147
Red cell distribution width/platelet ratio estimates the 3-year risk of decompensation in Metabolic Dysfunction-Associated Steatotic Liver Disease-induced cirrhosis 146
Exploring the Epidemiologic Burden, Pathogenetic Features, and Clinical Outcomes of Primary Liver Cancer in Patients with Type 2 Diabetes Mellitus (T2DM) and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Scoping Review 139
Systemic Oxidative Balance Reflects the Liver Disease Progression Status for Primary Biliary Cholangitis (Pbc): The Narcissus Fountain 133
Nutritional and Psychological Support as a Multidisciplinary Coordinated Approach in the Management of Chronic Liver Disease: A Scoping Review 128
Systemic Oxidative Stress Correlates with Sarcopenia and Pruritus Severity in Primary Biliary Cholangitis (PBC): Two Independent Relationships Simultaneously Impacting the Quality of Life—Is the Low Absorption of Cholestasis-Promoted Vitamin D a Puzzle Piece? 126
Clinical Applications of Artificial Intelligence (AI) in Human Cancer: Is It Time to Update the Diagnostic and Predictive Models in Managing Hepatocellular Carcinoma (HCC)? 124
Spleen Area Affects the Performance of the Platelet Count–Based Non-invasive Tools in Predicting First Hepatic Decompensation in Metabolic Dysfunction–Associated Steatotic Liver Disease Cirrhosis 123
From “Traditional” to “Trained” Immunity: Exploring the Novel Frontiers of Immunopathogenesis in the Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) 109
Letter: Different Risk of Acute Variceal Bleeding According to the Liver Disease Aetiology in Decompensated Cirrhosis Patients Receiving Carvedilol‐Based Primary Prophylaxis—May Insulin Resistance Unloose This Gordian Knot? 108
Phase Angle/C-reactive Protein-Index as a Novel Combined Tool for Predicting Liver-Related Hospitalizations in MASLD-Decompensated Cirrhosis 108
The Role of the Gut–Biliary–Liver Axis in Primary Hepatobiliary Liver Cancers: From Molecular Insights to Clinical Applications 108
Primary biliary cholangitis, Celiac Disease, and MASLD: the triumvirate of steatosis. How should we manage this triple overlap? 106
Beneficial Effects of Long-Lasting Bicarbonate–Sulfate–Calcium–Magnesium Water Intake on Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)-Related Outcomes via Impacting Intestinal Permeability (IP), IP-Related Systemic Inflammation, and Oxidative Stress 101
Managing Ascites and Kidney Dysfunction in Decompensated Advanced Chronic Liver Disease: From “One Size Fits All” to a Multidisciplinary-Tailored Approach 89
The Personalized Management of Primary Biliary Cholangitis in the Era of Precision Medicine: Current Challenges and Future Perspectives 46
From “MAFLD” to “MASLD”: Was This Revolution Worth It? A Head-to-Head Comparison of MAFLD and MASLD Criteria in Estimating Liver Disease Progression and Cardiovascular Risk in Real Life 45
Human Albumin-enriched Peritoneal Dialysis: A Novel Approach to Manage Refractory Ascites and Kidney Dysfunction in Decompensated Advanced Chronic Liver Disease 36
Contrast-enhanced ultrasound as a problem-solving tool and irreversible electroporation for a perivascular/peribiliary segment IVs colorectal liver metastasis: a case report 28
Beyond Insulin Resistance: Exploring the Centrality of the Gut–Liver Axis in Mediating Immunometabolic Dysregulation Driving Hepatocellular Carcinoma in MASLD and Diabetes 27
Redefining Liver Transplantation Indications for Hepatic Malignancies in the Era of Precision Transplant Oncology: An Up-to-Date Narrative Review 26
Peroxisome Proliferator-Activated Receptor (PPAR) Agonists in Chronic Liver Diseases: Translating Mechanistic Insights into Clinical Practice and Future Perspectives 20
Totale 2.188
Categoria #
all - tutte 5.762
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.762


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202411 0 0 0 0 0 0 0 0 2 1 4 4
2024/2025112 0 0 0 0 8 3 19 15 17 13 15 22
2025/20261.661 52 98 83 57 147 864 83 68 68 64 34 43
2026/2027404 17 64 155 168 0 0 0 0 0 0 0 0
Totale 2.188